Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

CCA urges NHSE to publish full list of DPPs amid ‘risk’ to trainee placements

The membership body has warned that a lack of designated prescribing practitioners (DPPs) could leave a “significant number of graduates” struggling to find employment.  

From 2025/26, NHS England (NHSE) has said that all foundation trainees “must have access to a designated prescribing practitioner (DPP) and a prescribing learning environment”.

But the sector has issued repeated warnings of an ongoing shortage of DPPs.

Today (May 23), the Company Chemists’ Association (CCA) demanded that the commissioner provides “a list of all organisations” that have spare DPPs.

The body said that it has “grave concerns” that “pharmacies will be unable to secure DPPs”.

It added that while NHSE has “repeatedly assured” the membership body that “there are sufficient DPPs within the system”, it is “hearing from pharmacies that they cannot find the DPPs that NHSE says are available”.

“If NHSE does not provide pharmacies with assistance in finding DPPs, pharmacy businesses will be forced to offer fewer foundation placements than they would like to,” it said.

“Consequently, a significant number of graduates leaving university next year will, unfortunately, struggle to find employment in their chosen career,” the CCA warned.

 

“NHSE must take control”

 

CCA chief executive Malcolm Harrison said that the organisation has “repeatedly warned NHSE about the short supply of DPPs”.

He added that “NHSE must take control of the situation and provide a full list of all organisations with available DPPs”.

“Employers do not want to be forced to remove foundation placements from [national recruitment scheme] Oriel, especially considering the existing workforce challenges,” he said.

“This risk to pharmacy graduate placements can be avoided if swift and decisive action is taken by NHSE now,” Harrison added.

C+D approached NHSE for comment. 

 

Ongoing concerns 

 

NHSE pharmacy dean for workforce training and education in the South West Nick Haddington said that the new funding can be used to “support pharmacy technicians and pharmacists to become education supervisors”.

Meanwhile, C+D revealed in March that Well Pharmacy would cut its trainee numbers by 75% in England due to the lack of DPPs.

The multiple said at the time that it offered “less than 30” places for English pharmacy trainees in the 2025/26 cohort and may “need to withdraw some of those places”.  

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD138209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel